Covid catalyses investment in biotech with 2022 set to be 'breakout' year

Tremendous potential, particularly in the spatial biology sector

clock • 4 min read

The pandemic has acted as a catalyst for the biotechnology and health industries, accelerating the pace at which new technologies are being adopted.

To continue reading this article...

Join Investment Week today

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Equities

Hargreaves Lansdown's Kate Marshall: UK opportunities beyond the crowded AI trade

Hargreaves Lansdown's Kate Marshall: UK opportunities beyond the crowded AI trade

Diversification potential

Kate Marshall
clock 04 August 2026 • 3 min read
Neuberger launches Japan Equity fund amid end of 'lost decades' of deflation

Neuberger launches Japan Equity fund amid end of 'lost decades' of deflation

Targets whole market cap spectrum

clock 30 July 2026 • 2 min read
JPMAM's Hugh Gimber: The right questions to tackle on tech

JPMAM's Hugh Gimber: The right questions to tackle on tech

Earnings season

Hugh Gimber
clock 27 July 2026 • 4 min read
Trustpilot